Pharma and Biotech
Notice of General Meeting & Posting of Circular | 02-Feb-2024 | 15:17 | RNS |
Convertible Loan Note Agreements | 02-Feb-2024 | 15:13 | RNS |
Fundraising and Proposed Capital Reorganisation | 30-Jan-2024 | 07:04 | RNS |
R&D Tax Credit | 30-Jan-2024 | 07:02 | RNS |
Half-year Report | 30-Jan-2024 | 07:00 | RNS |
Notice of Results | 23-Jan-2024 | 07:00 | RNS |
Patent Applications | 10-Jan-2024 | 07:00 | RNS |
Directorate Appointment | 14-Nov-2023 | 07:00 | RNS |
TR-1: Notification of major holdings | 24-Oct-2023 | 07:00 | RNS |
TR-1: Notification of major holdings | 20-Oct-2023 | 07:01 | RNS |
Director Dealing | 20-Oct-2023 | 07:00 | RNS |
Phase I Clinical Trial Results | 10-Oct-2023 | 07:00 | RNS |
Result of AGM | 29-Sep-2023 | 07:00 | RNS |
Final Dose Administered | 25-Sep-2023 | 07:00 | RNS |
Notice of AGM | 05-Sep-2023 | 16:18 | RNS |
Currency | UK Pounds |
Share Price | 0.16p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.30 |
52 Week Low | 0.14 |
Volume | 7,852,194 |
Shares Issued | 1,088.42m |
Market Cap | £1.69m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:23 | 1,243 @ 0.14p |
16:07 | 333,346 @ 0.14p |
15:30 | 500,000 @ 0.14p |
15:29 | 500,000 @ 0.14p |
15:26 | 176,552 @ 0.14p |
CEO | Clarissa Ann Sowemimo- Coke |
You are here: research